Roche Launches AI-Enabled Continuous Glucose Monitor in South Africa
Roche announced the availability of its Accu-Chek SmartGuide continuous glucose monitoring solution in South Africa.
This solution provides enhanced glucose monitoring and AI-enabled predictive insights for people with diabetes over 18.
Diabetes affects 4.2 million people in South Africa as of 2024, and if unmanaged, can lead to complications like cardiovascular disease and kidney disease.
Diabetes is one of today’s most urgent healthcare challenges.
- 4.2 million people in South Africa are living with diabetes
- Possible complications include cardiovascular disease, kidney disease, and nerve damage
Author's summary: Roche launches AI-enabled glucose monitor in South Africa.
More News
- Election Week comfort: mac & cheese, mashed potatoes and cocktails to soothe the soul
- Moonshadow Kitchen joins Sweet Farm in Himrod | Fingerlakes1.com
- Employers face £85bn in costs linked to ill-health ‘crisis’
- ActionAid warns: Aid cuts costing lives as another earthquake devastates Afghanistan
- Spotlight: Sudbury realtor is ‘crowned’ the winner in Reader Favourite Awards
- Puget Bench for Lightroom Classic v1.0 now available by Jose Antunes - ProVideo Coalition
- Government to join forces with employers to tackle ill-health
- The Great British Bake Off Crowns Its Season 16 Winner | www.98fm.com
- Nassau police officer Ian Fogarty honored by county legislature
- At COP30, Africa can lead the way to a sustainable future — but will it? (commentary)